Search Results for 'Galapagos Earns Janssen Milestone'

Search For:
Refine by Dates:
From: To:
Refine By Content:

  • Galapagos Earns Janssen Milestone

    January 16, 2013
    Delivers second preclinical drug candidate

  • Galapagos, Roche Expand Alliance into Fibrosis

    December 16, 2010
    Galapagos has achieved a $4.7 million milestone in its strategic alliance with Roche.

  • BMS, Alder Enter Global RA Drug Alliance

    November 10, 2009
    Bristol-Myers Squibb and Alder Biopharmaceuticals, Inc. entered a global agreement for the development and commercialization of ALD518, a biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.

  • Merck, Galapagos Enter Inflammatory Alliance

    April 20, 2009
    Galapagos NV has entered into a multi-year global strategic alliance with Merck, through an affiliate, to develop potential new therapies in inflammatory diseases.

  • Galapagos, AZ Enter 3rd Discovery Pact

    August 8, 2007
    Galapagos NV's service division, BioFocus DPI, has entered into a new drug discovery collaboration with AstraZeneca, under which BioFocus will perform medicinal chemistry, computational chemistry and support biology and ADMET services for AZ's infect…

  • Cytokinetics, GSK Amend Protein Pact

    November 28, 2006
    Cytokinetics, Inc. has amended its collaboration and license agreement with GlaxoSmithKline (GSK), under which Cytokinetics will assume responsibility for the costs of continued development of the kinesin spindle protein (KSP) inhibitors ispinesib (S…

  • Pfizer, TransTech Enter RAGE Pact

    September 18, 2006
    Pfizer and TransTech Pharma have entered into a license agreement for the development and commercialization of several of TransTech's small and large molecule compounds. These compounds target the receptor for advanced glycation endproducts (RAGE) an…